Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of female genital tuberculosis in women attending gynecological OPD in a tertiary care center, Himachal Pradesh, India.

The Indian journal of tuberculosis·2026
Same author

Post-hospitalized Health Conditions of Covid-19 patients: A Cross-sectional study in Bangladesh.

Mymensingh medical journal : MMJ·2026
Same author

Therapeutic Outcomes of Aloe vera Gel Compared with Triamcinolone Acetonide in Minor Aphthous Stomatitis.

Nigerian journal of clinical practice·2026
Same author

Comparison of Body Mass Index and Waist Circumference between Type 2 Diabetic and Non-diabetic Population of Chattogram, Bangladesh.

Mymensingh medical journal : MMJ·2026
Same author

Assessment of the Change of Blood pressure, Serum Total Cholesterol in Post Menopausal Women.

Mymensingh medical journal : MMJ·2025
Same author

Antibacterial effect of Nigella sativa (Kalojira) against Staphylococcus aureus and Escherichia coli.

Mymensingh medical journal : MMJ·2025

Related Experiment Video

Updated: Jul 4, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Techniques to develop and characterize nanosized formulation for salbutamol sulfate.

Bhavna1, F J Ahmad, R K Khar

  • 1Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India. bhavnano@gmail.com

Journal of Materials Science. Materials in Medicine
|June 11, 2008
PubMed
Summary

This study enhances pharmaceutical dry powder inhaler (DPI) dosing efficiency by creating nanosized salbutamol sulfate (SBM) particles. Spray drying proved optimal for producing stable, nanosized SBM for improved lung deposition.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Related Experiment Videos

Last Updated: Jul 4, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science
  • Nanotechnology

Background:

  • Pulmonary drug delivery requires efficient dosing for optimal therapeutic outcomes.
  • Dry powder inhalers (DPIs) are crucial for delivering antiasthmatic medications like salbutamol sulfate (SBM).
  • Current SBM formulations may have limitations in lung penetrability and deposition.

Purpose of the Study:

  • To enhance the dosing efficiency of pharmaceutical dry powder formulations for pulmonary inhalation.
  • To develop nanosized salbutamol sulfate (SBM) particles for improved drug penetrability and lung deposition.
  • To compare different techniques for producing nanosized SBM and identify an optimized formulation.

Main Methods:

  • Nanosized SBM particles were prepared using solvation, high-pressure homogenization, and spray drying.
  • Techniques were evaluated based on particle shape, size, and size distribution.
  • Optimized nanosized SBM formulation was characterized using TEM, SEM, and QELS for physical stability via FT-IR, DSC, and XRD.

Main Results:

  • Solvation yielded particles in the 2-10 µm range.
  • High-pressure homogenization produced particles of 50-100 nm but with low yield and long processing time.
  • Spray drying resulted in nanosized particles (50-100 nm) with higher yield and shorter processing time, showing no physical disparity compared to commercial SBM.

Conclusions:

  • Spray drying is an effective and efficient method for producing optimized nanosized salbutamol sulfate (SBM) particles for DPIs.
  • The developed nanosized SBM formulation demonstrates potential for enhanced lung deposition and therapeutic efficacy.
  • The physical stability of the nanosized SBM particles is confirmed, indicating suitability for pharmaceutical applications.